SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001393905-18-000012
Filing Date
2018-01-11
Accepted
2018-01-11 11:06:46
Documents
1
Period of Report
2018-01-03

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4/A  
1 PRIMARY DOCUMENT primary_doc.xml 4/A 3838
  Complete submission text file 0001393905-18-000012.txt   5675
Mailing Address 47 AVENUE ROAD SUITE 200 TORONTO A6 M5R 2G3
Business Address 47 AVENUE ROAD SUITE 200 TORONTO A6 M5R 2G3 416-929-1806
PORTAGE BIOTECH INC. (Reporting) CIK: 0001095435 (see all company filings)

State of Incorp.: A6 | Fiscal Year End: 0331
Type: 4/A | Act: 34 | File No.: 001-38080 | Film No.: 18523012
SIC: 1311 Crude Petroleum & Natural Gas
Office of Energy & Transportation

Mailing Address 234 CHURCH STREET, SUITE 304 NEW HAVEN CT 06510
Business Address 234 CHURCH STREET, SUITE 304 NEW HAVEN CT 06510 203-404-0410
Biohaven Pharmaceutical Holding Co Ltd. (Issuer) CIK: 0001689813 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences